Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2009 Nov 1.

Published in final edited form as: Hepatology. 2008 Nov;48(5):1549–1557. doi: 10.1002/hep.22517

Table 2.

Characteristics of Study Population at Study Entry (n=161)

	No Event (n=119)	Event (n=42)	p-value

Age	51.1 ± 8.8	53.0 ± 8.4	0.24

ELF	0.17 ± 0.72	1.10 ± 0.98	<0.0001
ELF	0.14	1.14	<0.0001

Ishak Score (0-6)	2.37 ± 1.34	3.14 ± 1.18	0.0008
Ishak Score (0-6)	2.0	3.0	0.0008

PBC Stage (1-4)	1.98 ± 0.70	2.50 ± 0.87	0.0009
PBC Stage (1-4)	1.0	1.75	0.0009

Bilirubin	0.54 ± 0.28	0.81 ± 0.53	0.002
Bilirubin	0.50	0.60	0.002

MELD	6.30 ± 0.66	7.02 ± 1.55	0.001
MELD	6.0	6.0	0.001

Mayo Risk	3.68 ± 0.64	4.15 ± 0.60	0.0001
Mayo Risk	3.66	4.21	0.0001

Results are expressed as mean ± standard deviation and median